Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	protein localization to M-band	ANK2 OBSCN	1.30e-05	2	75	2	GO:0036309
GeneOntologyCellularComponent	intercalated disc	XIRP1 ANK2 OBSCN TLN2	1.10e-04	68	76	4	GO:0014704
GeneOntologyCellularComponent	cell-cell contact zone	XIRP1 ANK2 OBSCN TLN2	3.84e-04	94	76	4	GO:0044291
Domain	VCX/VCY1	VCX2 VCX3A VCX	6.18e-07	5	75	3	IPR026653
Domain	VCX_VCY	VCX2 VCX3A VCX	6.18e-07	5	75	3	PF15231
Domain	Histone-fold	H2BC15 TAF3 H2BC5 H2BC3 SOS1	2.07e-05	83	75	5	IPR009072
Domain	Histone	H2BC15 H2BC5 H2BC3 SOS1	7.52e-05	56	75	4	PF00125
Domain	Histone_H2A/H2B/H3	H2BC15 H2BC5 H2BC3 SOS1	7.52e-05	56	75	4	IPR007125
Domain	H2B	H2BC15 H2BC5 H2BC3	7.85e-05	21	75	3	SM00427
Domain	HISTONE_H2B	H2BC15 H2BC5 H2BC3	7.85e-05	21	75	3	PS00357
Domain	Histone_H2B	H2BC15 H2BC5 H2BC3	7.85e-05	21	75	3	IPR000558
Domain	-	H2BC15 H2BC5 H2BC3 SOS1	1.70e-04	69	75	4	1.10.20.10
Domain	Znf_FYVE_PHD	TAF3 TCF20 CHD4 BSN KMT2E	3.13e-04	147	75	5	IPR011011
Domain	PHD	TAF3 TCF20 CHD4 KMT2E	4.52e-04	89	75	4	SM00249
Domain	Znf_PHD	TAF3 TCF20 CHD4 KMT2E	4.92e-04	91	75	4	IPR001965
Domain	GDS_CDC24_CS	PLEKHG1 OBSCN SOS1	5.12e-04	39	75	3	IPR001331
Domain	ZF_PHD_2	TAF3 TCF20 CHD4 KMT2E	5.79e-04	95	75	4	PS50016
Domain	ZF_PHD_1	TAF3 TCF20 CHD4 KMT2E	6.03e-04	96	75	4	PS01359
Domain	DH_1	PLEKHG1 OBSCN SOS1	2.08e-03	63	75	3	PS00741
Domain	-	TAF3 ZNF341 RNF20 CHD4 BSN KMT2E TRIM7	2.15e-03	449	75	7	3.30.40.10
Domain	Zinc_finger_PHD-type_CS	TAF3 CHD4 KMT2E	2.27e-03	65	75	3	IPR019786
Domain	CH	PARVA NAV2 LIMCH1	2.27e-03	65	75	3	SM00033
Domain	Znf_RING/FYVE/PHD	TAF3 ZNF341 RNF20 CHD4 BSN KMT2E TRIM7	2.43e-03	459	75	7	IPR013083
Domain	RhoGEF	PLEKHG1 OBSCN SOS1	2.58e-03	68	75	3	SM00325
Domain	RhoGEF	PLEKHG1 OBSCN SOS1	2.81e-03	70	75	3	PF00621
Domain	CH	PARVA NAV2 LIMCH1	2.81e-03	70	75	3	PF00307
Domain	DH_2	PLEKHG1 OBSCN SOS1	2.81e-03	70	75	3	PS50010
Domain	DH-domain	PLEKHG1 OBSCN SOS1	2.92e-03	71	75	3	IPR000219
Domain	-	PLEKHG1 OBSCN SOS1	2.92e-03	71	75	3	1.20.900.10
Domain	-	PARVA NAV2 LIMCH1	2.92e-03	71	75	3	1.10.418.10
Domain	CH	PARVA NAV2 LIMCH1	3.16e-03	73	75	3	PS50021
Domain	PHD	TAF3 CHD4 KMT2E	3.41e-03	75	75	3	PF00628
Domain	CH-domain	PARVA NAV2 LIMCH1	3.41e-03	75	75	3	IPR001715
Domain	Znf_PHD-finger	TAF3 CHD4 KMT2E	3.95e-03	79	75	3	IPR019787
Domain	FHA_DOMAIN	PHLDB1 MKI67	6.86e-03	31	75	2	PS50006
Domain	FHA	PHLDB1 MKI67	6.86e-03	31	75	2	PF00498
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	NCOA2 H2BC15 H2BC5 H2BC3 MED1	3.04e-06	63	51	5	MM15613
Pathway	REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA	H2BC15 H2BC5 H2BC3 DNMT1	1.14e-05	39	51	4	MM14850
Pathway	REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS	H2BC15 RNF20 H2BC5 H2BC3	2.03e-05	45	51	4	MM15508
Pathway	REACTOME_HATS_ACETYLATE_HISTONES	NCOA2 H2BC15 H2BC5 H2BC3	2.22e-05	46	51	4	MM14935
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	NCOA2 H2BC15 H2BC5 H2BC3 RELA CHD4	3.81e-05	175	51	6	MM14941
Pathway	REACTOME_HDACS_DEACETYLATE_HISTONES	H2BC15 H2BC5 H2BC3 CHD4	4.52e-05	55	51	4	MM14932
Pathway	REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP	H2BC15 ANAPC10 H2BC5 H2BC3 RELA	4.87e-05	111	51	5	M27187
Pathway	WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP	H2BC15 ANAPC10 H2BC5 H2BC3 RELA	5.08e-05	112	51	5	M48334
Pathway	REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS	H2BC15 RNF20 H2BC5 H2BC3	5.97e-05	59	51	4	M27763
Pathway	REACTOME_DNA_METHYLATION	H2BC15 H2BC5 H2BC3 DNMT1	8.23e-05	64	51	4	M27429
Pathway	REACTOME_PROTEIN_UBIQUITINATION	H2BC15 RNF20 H2BC5 H2BC3	8.74e-05	65	51	4	MM15490
Pathway	REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3	NCOA2 H2BC15 H2BC5 H2BC3	9.28e-05	66	51	4	M27488
Pathway	REACTOME_ESR_MEDIATED_SIGNALING	NCOA2 H2BC15 H2BC5 H2BC3 MED1	1.15e-04	133	51	5	MM15529
Pathway	REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA	H2BC15 H2BC5 H2BC3 DNMT1	1.30e-04	72	51	4	M27132
Pathway	REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION	H2BC15 H2BC5 H2BC3 CHD4	1.53e-04	75	51	4	M27343
Pathway	REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE	H2BC15 H2BC5 H2BC3	1.87e-04	31	51	3	MM17225
Pathway	REACTOME_PROTEIN_UBIQUITINATION	H2BC15 RNF20 H2BC5 H2BC3	1.87e-04	79	51	4	M27742
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	NCOA2 H2BC15 H2BC5 H2BC3 MED1	1.96e-04	149	51	5	M27888
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	NCOA2 PLEKHG1 H2BC15 BAIAP2L1 SYDE2 RNF20 OBSCN H2BC5 H2BC3 SOS1	2.16e-04	720	51	10	M41838
Pathway	REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES	H2BC15 H2BC5 H2BC3	3.18e-04	37	51	3	MM14883
Pathway	REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION	H2BC15 H2BC5 H2BC3	3.44e-04	38	51	3	MM15434
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_PKNS	NCOA2 H2BC15 H2BC5 H2BC3	3.50e-04	93	51	4	M27487
Pathway	REACTOME_HDACS_DEACETYLATE_HISTONES	H2BC15 H2BC5 H2BC3 CHD4	3.65e-04	94	51	4	M27230
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS	H2BC15 H2BC5 H2BC3 CHD4	4.11e-04	97	51	4	M48262
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	NCOA2 H2BC15 H2BC5 H2BC3 RELA CHD4	4.24e-04	272	51	6	M29619
Pathway	REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS	H2BC15 H2BC5 H2BC3	4.64e-04	42	51	3	M48029
Pathway	REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION	H2BC15 H2BC5 H2BC3	5.32e-04	44	51	3	MM15527
Pathway	REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH	H2BC15 H2BC5 H2BC3 DNMT1	5.35e-04	104	51	4	M29829
Pathway	REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION	H2BC15 H2BC5 H2BC3 CHD4	5.55e-04	105	51	4	M27425
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS	H2BC15 H2BC5 H2BC3 CHD4	5.96e-04	107	51	4	M48260
Pathway	REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS	NCOA2 H2BC15 H2BC5 H2BC3 MED1	6.14e-04	191	51	5	MM15586
Pathway	REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION	H2BC15 H2BC5 H2BC3 DNMT1	6.17e-04	108	51	4	M27426
Pathway	REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ	H2BC15 H2BC5 H2BC3	6.47e-04	47	51	3	MM15296
Pathway	REACTOME_ADIPOGENESIS	NCOA2 RELA CHD4 MED1	6.61e-04	110	51	4	M48259
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	H2BC15 H2BC5 H2BC3 CHD4	6.61e-04	110	51	4	M27696
Pathway	REACTOME_CELLULAR_SENESCENCE	H2BC15 ANAPC10 H2BC5 H2BC3 RELA	7.06e-04	197	51	5	M27188
Pathway	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	H2BC15 H2BC5 H2BC3	7.76e-04	50	51	3	MM15308
Pathway	REACTOME_CELLULAR_SENESCENCE	H2BC15 ANAPC10 H2BC5 H2BC3	8.88e-04	119	51	4	MM14901
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	CD19 SH3KBP1 SOS1	9.20e-04	53	51	3	MM15716
Pathway	REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE	H2BC15 H2BC5 H2BC3	9.72e-04	54	51	3	MM14904
Pathway	REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE	H2BC15 H2BC5 H2BC3	1.03e-03	55	51	3	M29526
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS	H2BC15 H2BC5 H2BC3	1.08e-03	56	51	3	MM17236
Pathway	REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE	H2BC15 H2BC5 H2BC3	1.14e-03	57	51	3	MM15298
Pathway	REACTOME_ESR_MEDIATED_SIGNALING	NCOA2 H2BC15 H2BC5 H2BC3 MED1	1.16e-03	220	51	5	M27794
Pathway	REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT	H2BC15 H2BC5 H2BC3 NOBOX	1.17e-03	128	51	4	M48019
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	CD19 SH3KBP1 RELA SOS1	1.27e-03	131	51	4	MM15717
Pathway	REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION	H2BC15 H2BC5 H2BC3	1.45e-03	62	51	3	M27700
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	H2BC15 H2BC5 H2BC3 DNMT1	1.46e-03	136	51	4	MM14848
Pathway	PID_BCR_5PATHWAY	CD19 RELA SOS1	1.52e-03	63	51	3	M10
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS	H2BC15 H2BC5 H2BC3 CHD4	1.71e-03	142	51	4	M48257
Pathway	REACTOME_HATS_ACETYLATE_HISTONES	NCOA2 H2BC15 H2BC5 H2BC3	1.71e-03	142	51	4	M27233
Pathway	REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION	H2BC15 H2BC5 H2BC3	1.82e-03	67	51	3	M27342
Pathway	REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE	H2BC15 H2BC5 H2BC3	1.82e-03	67	51	3	M39003
Pathway	REACTOME_BASE_EXCISION_REPAIR	H2BC15 H2BC5 H2BC3	1.82e-03	67	51	3	MM15429
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 MED1	1.89e-03	18	51	2	MM15034
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	NCOA2 MED1	1.89e-03	18	51	2	M26942
Pathway	REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ	H2BC15 H2BC5 H2BC3	1.89e-03	68	51	3	M27587
Pathway	REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION	H2BC15 H2BC5 H2BC3	1.89e-03	68	51	3	M27658
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX	H2BC15 H2BC5 H2BC3	2.06e-03	70	51	3	M48261
Pathway	REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT	H2BC15 H2BC5 H2BC3	2.06e-03	70	51	3	M48028
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	H2BC15 H2BC5 H2BC3 CHD4 DNMT1	2.18e-03	254	51	5	M27131
Pathway	REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	H2BC15 H2BC5 H2BC3	2.23e-03	72	51	3	M29714
Pathway	REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT	H2BC15 H2BC5 H2BC3	2.23e-03	72	51	3	MM15381
Pathway	REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES	H2BC15 H2BC5 H2BC3	2.32e-03	73	51	3	M27166
Pathway	REACTOME_TELOMERE_MAINTENANCE	H2BC15 H2BC5 H2BC3	2.41e-03	74	51	3	MM14605
Pathway	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	CD19 RELA SOS1	2.51e-03	75	51	3	M5436
Pathway	REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS	H2BC15 H2BC5 H2BC3	2.51e-03	75	51	3	MM15299
Pathway	REACTOME_INFLAMMASOMES	RELA AIM2	2.58e-03	21	51	2	M1072
Pathway	REACTOME_DNA_REPLICATION_PRE_INITIATION	H2BC15 ANAPC10 H2BC5 H2BC3	2.58e-03	159	51	4	M27665
Pathway	REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE	H2BC15 H2BC5 H2BC3	2.80e-03	78	51	3	M27589
Pathway	REACTOME_MEIOTIC_SYNAPSIS	H2BC15 H2BC5 H2BC3	2.80e-03	78	51	3	M1061
Pathway	PID_PDGFRA_PATHWAY	SHF SOS1	2.83e-03	22	51	2	M206
Pathway	REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE	H2BC15 H2BC5 H2BC3	2.91e-03	79	51	3	M27191
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	CD19 SH3KBP1 RELA SOS1	3.01e-03	166	51	4	M608
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GAPVD1 TAF3 TCF20 RNF20 MKI67 KIAA1958 ACIN1 TLN2 CHD4 LIMCH1 MED1 C2CD5 DNMT1 SOS1	1.79e-09	774	78	14	15302935
Pubmed	A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation.	VCX2 VCX3A VCX	4.33e-08	4	78	3	10903929
Pubmed	Epoxymicheliolide directly targets histone H2B to inhibit neuroinflammation via recruiting E3 ligase RNF20.	H2BC15 RNF20 H2BC3	1.08e-07	5	78	3	35074526
Pubmed	A human sex-chromosomal gene family expressed in male germ cells and encoding variably charged proteins.	VCX2 VCX3A VCX	1.08e-07	5	78	3	10607842
Pubmed	Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II.	H2BC15 RNF20 H2BC5 H2BC3	1.66e-07	22	78	4	16713563
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	H2BC15 ANK2 MKI67 H2BC5 ACIN1 H2BC3 CHD4 MED1	1.79e-07	271	78	8	32433965
Pubmed	Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation.	H2BC15 RNF20 H2BC5 H2BC3	2.01e-07	23	78	4	16307923
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PLEKHG1 GAPVD1 PHLDB1 TCF20 BAIAP2L1 SYNJ2 SYDE2 USP43 NAV2 LIMCH1 DNMT1 AHNAK2	4.77e-07	861	78	12	36931259
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	NCOA2 XIRP1 TCF20 GLI3 MKI67 BSN KMT2E	9.76e-07	233	78	7	37704626
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	AMBN ZNF469 TAF3 ANAPC10 GLI3 CAPRIN2 GPATCH2 H2BC3 CHD4 KIF18B AFF4 C2CD5 SOS1	1.14e-06	1116	78	13	31753913
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	H2BC15 TAF3 TCF20 MKI67 H2BC5 ACIN1 CHD4 MED1 KIF18B SMC5 AFF4 DNMT1	1.39e-06	954	78	12	36373674
Pubmed	Phosphorylation of histone H2B at DNA double-strand breaks.	H2BC15 H2BC5 H2BC3	1.77e-06	11	78	3	15197225
Pubmed	Histone modifications associated with somatic hypermutation.	H2BC15 H2BC5 H2BC3	1.77e-06	11	78	3	16039583
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	PHLDB1 SYNJ2 SH3KBP1 LIMCH1 DNMT1	4.64e-06	108	78	5	19531213
Pubmed	Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis.	USP43 H2BC3 CHD4	4.84e-06	15	78	3	30135474
Pubmed	Histone H2B as a functionally important plasminogen receptor on macrophages.	H2BC15 H2BC5 H2BC3	4.84e-06	15	78	3	17690254
Pubmed	E3 ubiquitin ligase TRIM7 negatively regulates NF-kappa B signaling pathway by degrading p65 in lung cancer.	RELA TRIM7	4.97e-06	2	78	2	31958511
Pubmed	Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases.	SPEG OBSCN	4.97e-06	2	78	2	15185077
Pubmed	Regulation of homologous recombination by RNF20-dependent H2B ubiquitination.	RNF20 H2BC3	4.97e-06	2	78	2	21362548
Pubmed	Structure of a cluster of mouse histone genes.	H2BC15 H2BC3	4.97e-06	2	78	2	8611618
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	NCOA2 NACA CAPRIN2 TLN2 BSN MYO5C	7.64e-06	208	78	6	33230847
Pubmed	Inhibition of core histones acetylation by carcinogenic nickel(II).	H2BC15 H2BC5 H2BC3	8.64e-06	18	78	3	16283522
Pubmed	Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase.	H2BC15 H2BC5 H2BC3	8.64e-06	18	78	3	12757711
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	GAPVD1 BAIAP2L1 SYDE2 GLI3 MKI67 GPRIN3 RELA CHD4 ANKRD50 DNMT1	9.35e-06	777	78	10	35844135
Pubmed	An endoplasmic reticulum stress regulator, Tmbim6, modulates secretory stage of mice molar.	AMBN GLI3 MKI67	1.20e-05	20	78	3	30963569
Pubmed	MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.	RELA DNMT1	1.49e-05	3	78	2	27259275
Pubmed	Coactivators for the orphan nuclear receptor RORalpha.	NCOA2 MED1	1.49e-05	3	78	2	10478845
Pubmed	DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction.	CD19 DNMT1	1.49e-05	3	78	2	19801979
Pubmed	Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.	ANK2 OBSCN	1.49e-05	3	78	2	18782775
Pubmed	DNMT1/miR-152-3p/SOS1 signaling axis promotes self-renewal and tumor growth of cancer stem-like cells derived from non-small cell lung cancer.	DNMT1 SOS1	1.49e-05	3	78	2	38622665
Pubmed	Wee1 epigenetically modulates H2B mono-ubiquitination at K120 lysine and DNA double-strand break repair through phosphorylation of H2BY37-dependent manner in small-cell lung cancer.	RNF20 H2BC3	1.49e-05	3	78	2	37102239
Pubmed	Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.	ANK2 OBSCN	1.49e-05	3	78	2	12527750
Pubmed	Analysis of the VCX3A, VCX2 and VCX3B genes shows that VCX3A gene deletion is not sufficient to result in mental retardation in X-linked ichthyosis.	VCX2 VCX3A	1.49e-05	3	78	2	18076704
Pubmed	Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.	H2BC15 H2BC5 H2BC3 RELA	2.27e-05	73	78	4	14657027
Pubmed	Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.	H2BC15 H2BC5 H2BC3 RELA	2.27e-05	73	78	4	9566873
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GAPVD1 SYNJ2 NACA CAPRIN2 NAV2 CACNA1G ANKRD50 BSN	2.51e-05	529	78	8	14621295
Pubmed	Nephronectin plays critical roles in Sox2 expression and proliferation in dental epithelial stem cells via EGF-like repeat domains.	AMBN MKI67	2.97e-05	4	78	2	28345658
Pubmed	RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer.	RNF20 H2BC3	2.97e-05	4	78	2	26854224
Pubmed	The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network.	RELA AFF4	2.97e-05	4	78	2	30659266
Pubmed	Neuromedin B and its receptor influence the activity of myometrial primary cells in vitro through regulation of Il6 expression via the Rela/p65 pathway in mice.	RELA NMB	2.97e-05	4	78	2	22262690
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA2 TCF20 RNF20 CHD4 MED1 AFF4	3.20e-05	268	78	6	33640491
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PLEKHG1 PHLDB1 ZNF341 SPEG OBSCN TIGD3 NAV2 TLN2 CNTROB AHNAK2 TRIM7	3.52e-05	1105	78	11	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PLEKHG1 PHLDB1 TCF20 SPEG ACIN1 LIMCH1 SMC5	3.69e-05	407	78	7	12693553
Pubmed	POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.	H2BC15 RNF20 GPATCH2 H2BC5 H2BC3 SOS1	3.84e-05	277	78	6	30745168
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	GAPVD1 BAIAP2L1 SYNJ2 SH3KBP1 PARVA USP43 NAV2 LIMCH1	3.99e-05	565	78	8	25468996
Pubmed	Characterization of histone H2A and H2B variants and their post-translational modifications by mass spectrometry.	H2BC15 H2BC5 H2BC3	4.22e-05	30	78	3	16319397
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	TCF20 MKI67 ACIN1 MED1 AFF4 DNMT1	4.33e-05	283	78	6	30585729
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GAPVD1 ANK2 NACA MKI67 ACIN1 CHD4 MED1 AFF4 DNMT1 AHNAK2	4.49e-05	934	78	10	33916271
Pubmed	Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines.	CD19 SOS1	4.94e-05	5	78	2	10706702
Pubmed	The novel function of Oct3/4 in mouse tooth development.	AMBN MKI67	4.94e-05	5	78	2	22159899
Pubmed	Distinct Requirements of CHD4 during B Cell Development and Antibody Response.	CD19 CHD4	4.94e-05	5	78	2	31042474
Pubmed	CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor.	NCOA2 RELA	4.94e-05	5	78	2	17932106
Pubmed	USP7 negatively controls global DNA methylation by attenuating ubiquitinated histone-dependent DNMT1 recruitment.	H2BC3 DNMT1	4.94e-05	5	78	2	32884836
Pubmed	Gene fusions AHRR-NCOA2, NCOA2-ETV4, ETV4-AHRR, P4HA2-TBCK, and TBCK-P4HA2 resulting from the translocations t(5;8;17)(p15;q13;q21) and t(4;5)(q24;q31) in a soft tissue angiofibroma.	NCOA2 TBCK	4.94e-05	5	78	2	27633981
Pubmed	CHD4 slides nucleosomes by decoupling entry- and exit-side DNA translocation.	H2BC3 CHD4	4.94e-05	5	78	2	32251276
Pubmed	A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.	NCOA2 MED1	4.94e-05	5	78	2	15026545
Pubmed	Testing gene function early in the B cell lineage in mb1-cre mice.	CD19 DNMT1	4.94e-05	5	78	2	16940357
Pubmed	2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts.	NCOA2 MED1	4.94e-05	5	78	2	12796488
Pubmed	T-type calcium channels functionally interact with spectrin (α/β) and ankyrin B.	ANK2 CACNA1G	4.94e-05	5	78	2	29720258
Pubmed	TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains.	H2BC3 CHD4 MED1	5.64e-05	33	78	3	33567268
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA2 TCF20 ANK2 SH3KBP1 TLN2 CHD4 LIMCH1 BSN AFF4 DNMT1	5.80e-05	963	78	10	28671696
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	GAPVD1 RNF20 MKI67 GPATCH2 CHD4 MED1 C2CD5	6.03e-05	440	78	7	34244565
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	TAF3 TCF20 MKI67 CHD4 MED1 KIF18B AFF4 DNMT1	6.67e-05	608	78	8	36089195
Pubmed	DNA Methyltransferase 1 Is Indispensable for Development of the Hippocampal Dentate Gyrus.	MKI67 DNMT1	7.40e-05	6	78	2	27251626
Pubmed	Nav2 hypomorphic mutant mice are ataxic and exhibit abnormalities in cerebellar development.	MKI67 NAV2	7.40e-05	6	78	2	21419114
Pubmed	The LIM homeodomain transcription factor LHX6: a transcriptional repressor that interacts with pituitary homeobox 2 (PITX2) to regulate odontogenesis.	AMBN MKI67	7.40e-05	6	78	2	23229549
Pubmed	Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205.	NCOA2 MED1	7.40e-05	6	78	2	12089346
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	TCF20 MKI67 ACIN1 CHD4	8.74e-05	103	78	4	32744500
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	TCF20 BAIAP2L1 NACA TLN2 RELA MED1 ANKRD50	9.34e-05	472	78	7	38943005
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	H2BC15 NACA H2BC5 ACIN1 H2BC3 CHD4 LIMCH1	9.97e-05	477	78	7	31300519
Pubmed	The Role of Epithelial Stat3 in Amelogenesis during Mouse Incisor Renewal.	AMBN MKI67	1.04e-04	7	78	2	29550820
Pubmed	Germinal center B cell maintenance and differentiation are controlled by distinct NF-κB transcription factor subunits.	CD19 RELA	1.04e-04	7	78	2	25180063
Pubmed	Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings.	NCOA2 MED1	1.04e-04	7	78	2	21478865
Pubmed	Expression pattern of Nav2 in the murine CNS with development.	MKI67 NAV2	1.04e-04	7	78	2	32081718
Pubmed	Expression patterns of key Sonic Hedgehog signaling pathway components in the developing and adult mouse midbrain and in the MN9D cell line.	GLI3 MKI67	1.04e-04	7	78	2	28799057
Pubmed	Talin regulates integrin β1-dependent and -independent cell functions in ureteric bud development.	MKI67 TLN2	1.04e-04	7	78	2	28993400
Pubmed	Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells.	NCOA2 MED1	1.04e-04	7	78	2	11117530
Pubmed	The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine.	NCOA2 MED1	1.04e-04	7	78	2	12709428
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	GAPVD1 RNF20 ACIN1 CHD4 DNMT1 AHNAK2	1.04e-04	332	78	6	32786267
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NCOA2 PHLDB1 ANAPC10 SYNJ2 FBXO42 TBCK OBSCN GPATCH2 SCNN1A FOLH1B LIMCH1 AFF4	1.15e-04	1489	78	12	28611215
Pubmed	Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks.	SYNJ2 SH3KBP1 RNF20 SOS1	1.17e-04	111	78	4	22558309
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	TCF20 MKI67 ACIN1 H2BC3 MED1 AFF4	1.21e-04	341	78	6	32971831
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	GAPVD1 PHLDB1 SPEG OBSCN NAV2 LIMCH1 SMC5	1.29e-04	497	78	7	36774506
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	GAPVD1 NACA PARVA LIMCH1 AHNAK2	1.29e-04	216	78	5	31519766
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ANK2 SH3KBP1 BSN ADD2 C2CD5 SOS1	1.33e-04	347	78	6	17114649
Pubmed	NSMCE2 suppresses cancer and aging in mice independently of its SUMO ligase activity.	CD19 MKI67	1.38e-04	8	78	2	26443207
Pubmed	The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.	NCOA2 MED1	1.38e-04	8	78	2	12082103
Pubmed	Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes.	SH3KBP1 SOS1	1.38e-04	8	78	2	11071869
Pubmed	Identification of the Novel Tooth-Specific Transcription Factor AmeloD.	AMBN MKI67	1.38e-04	8	78	2	30426815
Pubmed	Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.	NCOA2 MED1	1.38e-04	8	78	2	23178929
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	NCOA2 TCF20 RNF20 ACIN1 CHD4	1.40e-04	220	78	5	35785414
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	H2BC15 ANAPC10 TCF20 RNF20 MKI67 H2BC5 ACIN1 CHD4 MED1 KIF18B DNMT1	1.43e-04	1294	78	11	30804502
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	GAPVD1 BAIAP2L1 RNF20 MKI67 ACIN1 CHD4 MED1	1.43e-04	506	78	7	30890647
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	NCOA2 H2BC15 TCF20 GLI3 RELA CHD4 MED1 SSX3 DNMT1	1.52e-04	877	78	9	20211142
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	PHLDB1 NAV2 TLN2 CACNA1G SMC5	1.56e-04	225	78	5	12168954
Pubmed	Opposing ISWI- and CHD-class chromatin remodeling activities orchestrate heterochromatic DNA repair.	RNF20 H2BC3	1.77e-04	9	78	2	25533843
Pubmed	Gli3 null mice display glandular overgrowth of the developing stomach.	GLI3 MKI67	1.77e-04	9	78	2	16247775
Pubmed	Exocrine glands and the Chievitz organ of some mouse mutants.	FREM2 GLI3	1.77e-04	9	78	2	5088022
Pubmed	Limb and skin abnormalities in mice lacking IKKalpha.	MKI67 RELA	1.77e-04	9	78	2	10195895
Pubmed	A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.	BAIAP2L1 MKI67 LIMCH1 DNMT1	1.85e-04	125	78	4	21654808
Interaction	H2AC20 interactions	H2BC15 TCF20 TBCK RNF20 H2BC5 H2BC3 FAM227B CHD4 SMC5 DNMT1	2.95e-07	320	75	10	int:H2AC20
Interaction	PHF14 interactions	TCF20 CEP170P1 H2BC3 CHD4 SMC5 AIM2	1.96e-06	100	75	6	int:PHF14
Interaction	H2BC3 interactions	H2BC15 TCF20 RNF20 USP43 H2BC5 H2BC3 CHD4 MED1 KIF18B DNMT1	2.54e-06	406	75	10	int:H2BC3
Interaction	DUOX2 interactions	H2BC15 H2BC5 H2BC3 DNMT1	4.51e-06	30	75	4	int:DUOX2
Interaction	YWHAH interactions	NCOA2 PLEKHG1 GAPVD1 PHLDB1 TCF20 BAIAP2L1 SYNJ2 SYDE2 SPEG USP43 NAV2 LIMCH1 MED1 DNMT1 AHNAK2	1.10e-05	1102	75	15	int:YWHAH
Interaction	H2BC13 interactions	ZNF469 H2BC15 MKI67 H2BC5 H2BC3 CHD4 SMC5	1.31e-05	210	75	7	int:H2BC13
Interaction	H3C1 interactions	TAF3 ANK2 NACA MKI67 NAV2 FOLH1B H2BC5 H2BC3 CHD4 KIF18B SMC5 AFF4 DNMT1	2.53e-05	901	75	13	int:H3C1
Interaction	TAF9 interactions	NCOA2 TAF3 ANK2 GLI3 RELA SMC5	2.82e-05	159	75	6	int:TAF9
Interaction	BRD2 interactions	TAF3 CAPRIN2 ACIN1 H2BC3 CHD4 MED1 SMC5 C2CD5 DNMT1	2.99e-05	429	75	9	int:BRD2
Interaction	TAF6 interactions	TAF3 SH3KBP1 MKI67 H2BC3 RELA CHD4 SMC5	3.54e-05	245	75	7	int:TAF6
Interaction	RBM15B interactions	NAV2 CEP170P1 CHD4 ANKRD50 SMC5	3.74e-05	101	75	5	int:RBM15B
Interaction	H2BC9 interactions	ZNF469 H2BC15 SYNJ2 H2BC5 H2BC3 CHD4 SMC5 AFF4 DNMT1	4.05e-05	446	75	9	int:H2BC9
Interaction	H2BC1 interactions	H2BC15 TCF20 H2BC5 H2BC3 CHD4 SMC5	5.30e-05	178	75	6	int:H2BC1
Interaction	CYLC1 interactions	H2BC15 H2BC5 H2BC3	5.39e-05	20	75	3	int:CYLC1
Interaction	SUMO2 interactions	GAPVD1 NACA RNF20 MKI67 ACIN1 CHD4 KIF18B SMC5 DNMT1 AHNAK2	6.51e-05	591	75	10	int:SUMO2
Interaction	LYN interactions	ANK2 CD19 BAIAP2L1 ZDHHC23 TBCK SH3KBP1 GPRIN3 ANKRD50 ADD2 C2CD5 AHNAK2	6.84e-05	720	75	11	int:LYN
Interaction	ADARB1 interactions	H2BC15 TCF20 ANK2 MKI67 H2BC5 ACIN1 H2BC3 CHD4 MED1	8.22e-05	489	75	9	int:ADARB1
Interaction	CDK5R2 interactions	H2BC15 H2BC5 H2BC3	8.31e-05	23	75	3	int:CDK5R2
Interaction	TNN interactions	H2BC15 H2BC5 H2BC3	8.31e-05	23	75	3	int:TNN
Interaction	KIF18B interactions	MKI67 H2BC3 KIF18B SMC5	9.49e-05	64	75	4	int:KIF18B
Interaction	PPIA interactions	PHLDB1 TAF3 TCF20 BAIAP2L1 NACA RNF20 MKI67 TLN2 RELA MED1 ANKRD50 SMC5	1.00e-04	888	75	12	int:PPIA
Interaction	CDH1 interactions	GAPVD1 ANAPC10 BAIAP2L1 SYNJ2 SH3KBP1 PARVA MKI67 USP43 NAV2 CHD4 LIMCH1	1.21e-04	768	75	11	int:CDH1
Interaction	MDC1 interactions	ANAPC10 TCF20 SH3KBP1 MKI67 H2BC3 CHD4 SMC5 AIM2	1.50e-04	414	75	8	int:MDC1
Interaction	BAZ2A interactions	MKI67 CHD4 SMC5 DNMT1	1.59e-04	73	75	4	int:BAZ2A
Interaction	NCOA6 interactions	NCOA2 MKI67 RELA MED1 SMC5	2.07e-04	145	75	5	int:NCOA6
Interaction	TCF20 interactions	TCF20 H2BC3 CHD4 SMC5 AIM2	2.14e-04	146	75	5	int:TCF20
Interaction	H2AC18 interactions	H2BC15 RNF20 H2BC5 H2BC3 AIM2	2.28e-04	148	75	5	int:H2AC18
Interaction	NAA40 interactions	GAPVD1 ANK2 NACA MKI67 ACIN1 CHD4 LIMCH1 MED1 SMC5 AFF4 DNMT1 AHNAK2	2.47e-04	978	75	12	int:NAA40
Interaction	H2BC21 interactions	H2BC15 ANAPC10 TCF20 RNF20 OBSCN MKI67 H2BC5 H2BC3 CHD4 KIF18B	2.47e-04	696	75	10	int:H2BC21
Interaction	NUP50 interactions	TAF3 TCF20 NACA H2BC5 MED1 KIF18B SMC5	2.76e-04	341	75	7	int:NUP50
Interaction	SMC5 interactions	H2BC15 TAF3 TCF20 MKI67 H2BC5 ACIN1 CHD4 MED1 KIF18B SMC5 AFF4 DNMT1	3.03e-04	1000	75	12	int:SMC5
Interaction	H2AC11 interactions	H2BC15 TAF3 H2BC5 H2BC3 CHD4 AHNAK2	3.24e-04	248	75	6	int:H2AC11
Cytoband	Ensembl 112 genes in cytogenetic band chr6p22	H2BC15 OR2B2 H2BC5 H2BC3 OR2B6	5.04e-04	378	79	5	chr6p22
Cytoband	Xp22	VCX3A VCX	8.55e-04	25	79	2	Xp22
Cytoband	Ensembl 112 genes in cytogenetic band chrXp22	VCX2 VCX3A SH3KBP1 VCX	9.36e-04	250	79	4	chrXp22
GeneFamily	Variable charge X/Y family	VCX2 VCX3A VCX	5.90e-07	6	57	3	368
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG1 OBSCN SOS1	1.18e-03	66	57	3	722
GeneFamily	PHD finger proteins	TAF3 CHD4 KMT2E	2.87e-03	90	57	3	88
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SCNN1A NAV2 GPRIN3 LIMCH1 MYO5C	9.96e-07	186	79	6	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD19 ZDHHC23 TIGD3 SSX3 AIM2	8.61e-06	156	79	5	4e4b94580969a9736ca28df79715535a4bd1f9b2
ToppCell	Control\|World / group, cell type (main and fine annotations)	FREM2 BAIAP2L1 NAV2 LIMCH1 MYO5C	1.23e-05	168	79	5	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	PLEKHG1 PARVA NAV2 LIMCH1 MYO5C	1.31e-05	170	79	5	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 MKI67 H2BC3 CHD4 DNMT1	1.42e-05	173	79	5	a5172dee859bf6c2eed46c48bd64dfef0ff9f28f
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 MKI67 H2BC3 CHD4 DNMT1	1.42e-05	173	79	5	639b5b0b33ce5aa0bc26363c059717012ddc14c0
ToppCell	-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	H2BC15 CD19 MKI67 H2BC5 AIM2	1.59e-05	177	79	5	ae2d2e138946535596fa30a55207f261cafda461
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SCNN1A NAV2 GPRIN3 LIMCH1 MYO5C	1.59e-05	177	79	5	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FREM2 SCNN1A NAV2 LIMCH1 MYO5C	1.67e-05	179	79	5	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SCNN1A NAV2 LIMCH1 MYO5C	1.67e-05	179	79	5	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SCNN1A NAV2 LIMCH1 MYO5C	1.77e-05	181	79	5	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYDE2 SCNN1A NAV2 LIMCH1 MYO5C	1.86e-05	183	79	5	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	SYDE2 SCNN1A NAV2 LIMCH1 MYO5C	1.86e-05	183	79	5	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PARVA SCNN1A NAV2 LIMCH1 MYO5C	1.91e-05	184	79	5	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PARVA SCNN1A NAV2 LIMCH1 MYO5C	1.91e-05	184	79	5	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FREM2 NAV2 GPRIN3 LIMCH1 MYO5C	1.96e-05	185	79	5	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	BAIAP2L1 SCNN1A NAV2 LIMCH1 MYO5C	1.96e-05	185	79	5	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SCNN1A NAV2 LIMCH1 MYO5C	2.01e-05	186	79	5	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SCNN1A NAV2 LIMCH1 MYO5C	2.07e-05	187	79	5	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	BAIAP2L1 SCNN1A NAV2 LIMCH1 MYO5C	2.12e-05	188	79	5	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	FREM2 BAIAP2L1 SCNN1A LIMCH1 MYO5C	2.12e-05	188	79	5	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Chromophobe-6\|TCGA-Kidney / Sample_Type by Project: Shred V9	VCX2 VCX3A CACNA1G VCX	2.19e-05	92	79	4	965a0ebf4b1ad3eaad839b96995ea6712c5d3357
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FREM2 MKI67 H2BC3 KIF18B MYO5C	2.29e-05	191	79	5	39220f4a345e328f7fa4fd462a0abeea821b3e02
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FREM2 SCNN1A NAV2 LIMCH1 MYO5C	2.29e-05	191	79	5	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PLEKHG1 FREM2 USP43 KIF18B MYO5C	2.34e-05	192	79	5	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	FREM2 SCNN1A NAV2 LIMCH1 MYO5C	2.34e-05	192	79	5	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	SYNJ2 TBCK KMT2E AFF4 SOS1	2.34e-05	192	79	5	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	CAPRIN2 MKI67 KIF18B CNTROB AHNAK2	2.34e-05	192	79	5	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PLEKHG1 FREM2 ANK2 SCNN1A MYO5C	2.34e-05	192	79	5	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Control / Condition, Lineage and Cell class	H2BC15 MKI67 NAV2 H2BC3 KIF18B	2.40e-05	193	79	5	33d409d6ed1c606337248587ad997ac5f67f081d
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FREM2 GAPVD1 BAIAP2L1 ZDHHC23 USP43	2.40e-05	193	79	5	0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	SYNJ2 TBCK KMT2E AFF4 SOS1	2.40e-05	193	79	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PHLDB1 GLI3 NAV2 TLN2 DNMT1	2.40e-05	193	79	5	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FREM2 SCNN1A NAV2 LIMCH1 MYO5C	2.46e-05	194	79	5	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MKI67 SCNN1A KIF18B STK31 MYO5C	2.46e-05	194	79	5	d790cfff3664e46fe2fd2f6b0c26896799927845
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PHLDB1 ANK2 GLI3 TLN2 DNMT1	2.52e-05	195	79	5	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	H2BC15 MKI67 H2BC3 KIF18B DNMT1	2.52e-05	195	79	5	93c345e70d6c8ff5d12fd63d73228c1700b804a0
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 CD19 NMB AIM2 ADD2	2.65e-05	197	79	5	e4b4fa219322b3250b482f8e242f41e8b05485db
ToppCell	BL-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BAIAP2L1 PARVA SCNN1A MYO5C AHNAK2	2.72e-05	198	79	5	6218a25b94d5fa2c69880539adf9c63bfe52dcd3
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FREM2 SCNN1A KIAA1958 LIMCH1 MYO5C	2.78e-05	199	79	5	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FREM2 SCNN1A KIAA1958 LIMCH1 MYO5C	2.78e-05	199	79	5	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FREM2 SCNN1A KIAA1958 LIMCH1 MYO5C	2.78e-05	199	79	5	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FREM2 SCNN1A KIAA1958 LIMCH1 MYO5C	2.78e-05	199	79	5	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	GLI3 NAV2 LIMCH1 CNTROB	7.26e-05	125	79	4	6cd741dd1c7ee6b16437cca7c15c99b5c95603fc
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_activate-7\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHG1 CD19 AIM2 AHNAK2	8.97e-05	132	79	4	c07842a4b514f1e950c8af303f3b6b4275906e6a
ToppCell	PBMC-Mild-cDC_2\|Mild / Compartment, Disease Groups and Clusters	PLEKHG1 FREM2 SYDE2 AHNAK2	9.78e-05	135	79	4	cb9d834f8301cf53f20e09c3f4cb6a148690196a
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ANK2 SYDE2 CACNA1G STK31	1.16e-04	141	79	4	7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF469 SH3KBP1 GPRIN3 AIM2	1.19e-04	142	79	4	f720f13b339589fa924a42e89393e5db0b26300b
ToppCell	mild_COVID-19-B_cell\|World / disease group, cell group and cell class (v2)	PLEKHG1 SYNJ2 SYDE2 GLI3	1.22e-04	143	79	4	4698cc877dda9b1ef7d6f18c9adc869ef791b1d8
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Pro-B\|bone_marrow / Manually curated celltypes from each tissue	CD19 STK31 CLHC1 MYO5C	1.71e-04	156	79	4	b093dbba6662e4fffc8aa577587b77f64ac44b56
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHG1 ZNF469 CD19 ADD2	1.79e-04	158	79	4	41cf950983f47a9e55d56041b301006b42853b37
ToppCell	cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 GLI3 NAV2 H2BC3	1.88e-04	160	79	4	9049707a4487f2337a17976ceb5fbd8815ab9e1d
ToppCell	cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 GLI3 NAV2 H2BC3	1.88e-04	160	79	4	f2cfec54cf48a655f473b830be7d141c54b521ff
ToppCell	wk_15-18-Hematologic-Meg-ery-Platelet\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	H2BC15 PROB1 OR2B6 AIM2	1.88e-04	160	79	4	768f3cefc3ad4cda229e598cce8bde574cf64bb2
ToppCell	cellseq2-Epithelial-Epithelial_Neuro-Secretory\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 GLI3 NAV2 H2BC3	1.88e-04	160	79	4	0eb50b3c494e1b65d40104b3b5411b57bb72b959
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_2\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	SPEG MKI67 H2BC3 KIF18B	1.97e-04	162	79	4	a957c7e347189b72fbd47db3075bb5e879a21c67
ToppCell	facs-Spleen-nan-18m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MKI67 CACNA1G KIF18B ADD2	2.16e-04	166	79	4	8d535fab019356894b4dad3fbdbc4d2ad3e16082
ToppCell	facs-Spleen-nan-18m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MKI67 CACNA1G KIF18B ADD2	2.16e-04	166	79	4	f56b1c0d6cb5353a16a2598bda905287f16d2c39
ToppCell	facs-Spleen-nan-18m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MKI67 CACNA1G KIF18B ADD2	2.16e-04	166	79	4	a5074c96c6561273029aceb93402a7e038140f50
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOA2 FBXO42 KIAA1958 CACNA1G	2.21e-04	167	79	4	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF341 TIGD3 CACNA1G ADD2	2.27e-04	168	79	4	17fb9426eeea407b26fb895b8397faca95b7552d
ToppCell	facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF341 TIGD3 CACNA1G ADD2	2.27e-04	168	79	4	a61b39884851384cffd430079040546d125b2b40
ToppCell	AT1-AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	SYDE2 PARVA LIMCH1 AHNAK2	2.32e-04	169	79	4	815474855a70498a74e52f6583113c63b7267a0c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MKI67 KIF18B CNTROB DNMT1	2.32e-04	169	79	4	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SH3KBP1 MKI67 H2BC3 DNMT1	2.32e-04	169	79	4	b08567ecfa3f8d83e7990330fc1b27f0bb7e75a1
ToppCell	368C-Lymphocytic-ILC\|368C / Donor, Lineage, Cell class and subclass (all cells)	H2BC15 ZNF341 H2BC3 GPRIN3	2.42e-04	171	79	4	3b3143e4aa6520ee9c6b6f2482206ad3d8205d14
ToppCell	368C-Lymphocytic-ILC-ILC-2\|368C / Donor, Lineage, Cell class and subclass (all cells)	H2BC15 ZNF341 H2BC3 GPRIN3	2.42e-04	171	79	4	fd01076574dcc82bfd4a1538812500543b16794f
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MKI67 H2BC5 KIF18B DNMT1	2.48e-04	172	79	4	282017db72d0537ac82aecc69393ccde9590be60
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	PARVA SCNN1A NAV2 LIMCH1	2.53e-04	173	79	4	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	H2BC15 H2BC5 H2BC3 AIM2	2.59e-04	174	79	4	ba50cc04fcdee1926d4af4787ac86555ae9632cc
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	PARVA NAV2 LIMCH1 MYO5C	2.59e-04	174	79	4	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHG1 CD19 MED1 CNTROB	2.70e-04	176	79	4	dde46f06f6fc3f7ba83be91a0ee6231790955e3e
ToppCell	COVID-19_Moderate-B_intermediate\|COVID-19_Moderate / disease group, cell group and cell class	PLEKHG1 ANK2 CD19 AIM2	2.76e-04	177	79	4	68e3d12a0c048a2d0f1b9680c7338a35855bba30
ToppCell	368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MKI67 ANKRD50 KIF18B OR2B6	2.76e-04	177	79	4	26c25d10aa511b64cc7db43a8deea7b5d31bca96
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SCNN1A GPRIN3 LIMCH1 MYO5C	2.82e-04	178	79	4	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	Healthy-B_memory\|World / disease group, cell group and cell class	PLEKHG1 CD19 ZDHHC23 AIM2	2.82e-04	178	79	4	b4848b95f2b449c9fac9b5560d959af1788a6f3b
ToppCell	facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHLDB1 MKI67 H2BC3 BSN	2.88e-04	179	79	4	5297f7459b40ca780a1983fecc1bb9c035c7677e
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	SCNN1A NAV2 LIMCH1 MYO5C	2.88e-04	179	79	4	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SYDE2 NAV2 LIMCH1 MYO5C	2.88e-04	179	79	4	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHG1 NBAS TCF20 CD19	2.95e-04	180	79	4	9f4bbaf6435c23e3e552ae22be8ea7884314192d
ToppCell	BAL-Severe-Lymphocyte-B-B_cell-B_cell\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHG1 NBAS TCF20 CD19	2.95e-04	180	79	4	b465f2f8b0e9a2034a4f1272bb00c77439164dbf
ToppCell	BAL-Severe-Lymphocyte-B-B_cell\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHG1 NBAS TCF20 CD19	2.95e-04	180	79	4	c3c72531af5b9f7a7416727fe609dab5180e03b6
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	H2BC15 MKI67 H2BC3 DNMT1	3.01e-04	181	79	4	9fce5eee75684a7ecac6996e26e9215bc95098b2
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	H2BC15 MKI67 H2BC3 DNMT1	3.01e-04	181	79	4	ad97e802e934738ddece675232a72308db2da256
ToppCell	Healthy-B_memory\|Healthy / disease group, cell group and cell class	PLEKHG1 CD19 ZDHHC23 AIM2	3.01e-04	181	79	4	7b903076efb90026b9845af0c7a840901451193a
ToppCell	COVID-19_Moderate-B_memory\|COVID-19_Moderate / disease group, cell group and cell class	CD19 ZDHHC23 AIM2 ADD2	3.07e-04	182	79	4	bbdbef62389ac062118cc0c7979686393399f2c8
ToppCell	normal_Lung-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	PLEKHG1 MKI67 CACNA1G KIF18B	3.07e-04	182	79	4	8dd79fef8f8463ad3194f9cc07c6cacf2c886304
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SCNN1A NAV2 MYO5C	3.14e-04	183	79	4	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SCNN1A LIMCH1 MYO5C	3.20e-04	184	79	4	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	P28-Epithelial\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	BAIAP2L1 SCNN1A NAV2 MYO5C	3.20e-04	184	79	4	05811d13bd8a602095a3fcf5e55345edadc7b8bf
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	FREM2 SCNN1A LIMCH1 MYO5C	3.20e-04	184	79	4	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 SCNN1A NAV2 MYO5C	3.20e-04	184	79	4	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SCNN1A NAV2 LIMCH1 MYO5C	3.20e-04	184	79	4	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	Healthy/Control-B_memory\|World / Disease group and Cell class	CD19 ZDHHC23 NAV2 AIM2	3.20e-04	184	79	4	9e1879d86b535ede9b47deb0752e291f987a5d5e
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	XIRP1 ANK2 OBSCN LIMCH1	3.20e-04	184	79	4	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHG1 FREM2 SCNN1A LIMCH1	3.20e-04	184	79	4	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SYDE2 NAV2 LIMCH1 MYO5C	3.27e-04	185	79	4	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHG1 SCNN1A LIMCH1 MYO5C	3.27e-04	185	79	4	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	ANK2 GLI3 NAV2 TLN2	3.27e-04	185	79	4	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 GPRIN3 LIMCH1 MYO5C	3.27e-04	185	79	4	3937e026add96a396122139daf8011cfbc60e75c
Disease	nephrotic syndrome (implicated_via_orthology)	GAPVD1 SH3KBP1 SCNN1A	3.32e-05	24	77	3	DOID:1184 (implicated_via_orthology)
Disease	brain connectivity measurement	PLEKHG1 ANAPC10 GLI3 SH3KBP1 NAV2 CLHC1 SOS1	8.49e-05	400	77	7	EFO_0005210
Disease	lymphoma (is_implicated_in)	RELA CHD4	1.00e-04	6	77	2	DOID:0060058 (is_implicated_in)
Disease	vital capacity	H2BC15 ANAPC10 TCF20 ZNF341 GLI3 CAPRIN2 FOLH1B GPRIN3 MED1 KMT2E STK31	3.52e-04	1236	77	11	EFO_0004312
Disease	putamen volume change measurement	TAF3 SYDE2	5.15e-04	13	77	2	EFO_0021495
Disease	fertility measurement	NBAS NAV2	5.99e-04	14	77	2	EFO_0006923
Disease	Colonic Neoplasms	SH3KBP1 MKI67 RELA DNMT1	6.84e-04	152	77	4	C0009375
Disease	prostate cancer (is_marker_for)	NCOA2 KMT2E DNMT1 SOS1	7.54e-04	156	77	4	DOID:10283 (is_marker_for)
Disease	Malignant tumor of colon	SH3KBP1 MKI67 RELA DNMT1	8.09e-04	159	77	4	C0007102
Disease	Hepatitis	NAV2 ANKRD50	1.50e-03	22	77	2	HP_0012115
Disease	complement factor H-like 1 protein measurement	FREM2 SYNJ2	1.50e-03	22	77	2	EFO_0600092
Disease	diastolic blood pressure, systolic blood pressure	GAPVD1 ANK2 SPEG FOLH1B TLN2 KMT2E CNTROB	1.83e-03	670	77	7	EFO_0006335, EFO_0006336
Disease	stimulant use measurement	NCOA2 NBAS	2.43e-03	28	77	2	EFO_0600076

Protein segments in the cluster

Peptide	Gene	Start	Entry
KLPKMPEAVGTDPST	ACIN1	41	Q9UKV3
SSRAGPGKMQEPPKS	FAM227B	11	Q96M60
GEPGTSMPPEKKAAV	RNF20	11	Q5VTR2
GMADANSPPKPLSKP	DNMT1	121	P26358
KMKGLPSVTPAAADP	AMBN	371	Q9NP70
TKPKPLSQAEMSPAA	AIM2	96	O14862
AKSGTAAPPKQMPAE	ANKRD50	1311	Q9ULJ7
LGSKAVGMPSPVSPK	AFF4	1046	Q9UHB7
MVPPGKKPAGEASNS	C17orf113	1	A0A1B0GUU1
MPEPSKSAPAPKKGS	H2BC15	1	Q99877
QKKPNAMGLAPTSSP	NOBOX	206	O60393
SSPVEPKMKAGIFPS	ANK2	2471	Q01484
MSSKGPSASAALSPP	FBXO42	566	Q6P3S6
QPPSPSSKDQGKMVS	OR2B6	261	P58173
KAEKPMTSQPSPGGQ	GLI3	696	P10071
APKGSSSSEPMVPPQ	FREM2	3146	Q5SZK8
PAKPGKSSSLEMTPY	GAPVD1	446	Q14C86
PHSQPSSAPAMPKKG	BSN	3681	Q9UPA5
MPEPTKSAPAPKKGS	H2BC5	1	P58876
KKSPSPEFSGMPRIS	FOLH1B	191	Q9HBA9
NTCKSPPKMSKPGSP	KMT2E	1346	Q8IZD2
GKTTKMPCESSPPES	MKI67	1366	P46013
PSAGKAMDTPKPAVS	MKI67	2381	P46013
TMKGPKPTSSLPGTS	KIF18B	766	Q86Y91
PKIPEKDGQMLSPSS	NBAS	1831	A2RRP1
APAKASPPLDSKMGP	OBSCN	7086	Q5VST9
MPEPSKSAPAPKKGS	H2BC3	1	P33778
MTTPNKTPPGADPKQ	ANAPC10	1	Q9UM13
MPDPSKSAPAPKKGS	H2BU1	1	Q8N257
TLSKCSPKMPPAPSG	BAIAP2L1	276	Q9UHR4
SGPPDSMAASPSPKK	CACNA1G	2346	O43497
SEGPSSPSGKLMSPK	CD19	141	P15391
GFPSAMLPSPPKQKS	CEP170P1	216	Q96L14
SSLASPNPPMAKGSE	CAPRIN2	726	Q6IMN6
IKKSGGTPTSMVPIP	GPATCH2	356	Q9NW75
PMGDSSPGSGKKTPS	GPRIN3	611	Q6ZVF9
ENKKMSQPGSPSPKT	CHD4	1526	Q14839
SSPPQSTPGLMKGNK	SCNN1A	11	P37088
PPAKAMTVEKASPVG	C2CD5	841	Q86YS7
PPARKKSGHPAPSSM	CNTROB	881	Q8N137
SRPPGGSDKLASPMK	MED1	1196	Q15648
GSDKLASPMKPVPGT	MED1	1201	Q15648
SGSPSKTVTPKAVPM	LIMCH1	521	Q9UPQ0
QPPSPSSKDRGKMVS	OR2B2	261	Q9GZK3
MEPSSPNPSPVKKGS	SYDE2	496	Q5VT97
KAKLGTPSNMPPNFP	TAF3	476	Q5VWG9
MSPKPRASGPPAKAT	VCX3A	1	Q9NNX9
PPPPTGLMVKKSASD	SYNJ2	1111	O15056
DPSGAAVPEMPKKSS	NAV2	546	Q8IVL1
KASLPPKPGTMAAGG	SH3KBP1	546	Q96B97
PPGKPTTSEKINMIS	SSX3	141	Q99909
MATSPQKSPSVPKSP	PARVA	1	Q9NVD7
MQASPSPGIAPKPKT	PROB1	806	E7EW31
SSPSKIMSKHLDSPP	SOS1	1166	Q07889
PEGPLKLKASSTDMP	AHNAK2	5351	Q8IVF2
PMSPEGSPSKSPSKK	ADD2	691	P35612
TFSKDPSKPIPGMTL	CLHC1	156	Q8NHS4
PPPLSKMGSLDSKDC	NCOA2	571	Q15596
SPELKMGKPASPGSD	STK31	896	Q9BXU1
APGKTPPSSHKTSEM	TIGD3	366	Q6B0B8
AGNPKSAKPLSMEPS	SHF	291	Q7M4L6
KESFQMGSKSSPPSP	USP43	956	Q70EL4
FKPKGPNPAAPMTSA	ZNF341	271	Q9BYN7
PGPKPTTVSSEMKNK	TRIM7	296	Q9C029
MSPKPRASGPPAKAT	VCX2	1	Q9H322
SGPSSKLEKMPSIPE	SPEG	1161	Q15772
PMKSPAPGNVAASKS	SARG	426	Q9BW04
AMSKAPGAPGPKAAE	PLPPR3	541	Q6T4P5
MGKKSLEPSSPSPLG	NMB	56	P08949
AAGKKPAATSPLSPM	PHLDB1	211	Q86UU1
SPAKSSGPPGMSSQK	TCF20	1196	Q9UGU0
DHMPSKKPLPSGPKS	TBCK	171	Q8TEA7
MSPKPRASGPPAKAT	VCX	1	Q9H320
DPKGSSKMPAGSPTK	ZDHHC23	241	Q8IYP9
MKPATPKAKPGPSSQ	ZNF469	3691	Q96JG9
MSKLDEGTPPEPKGT	TLN2	1836	Q9Y4G6
MLKPSGTPFSPDKVG	ZBED9	671	Q6R2W3
PSGNLSMPHKPVSDK	PLEKHG1	816	Q9ULL1
MATPSKKTSTPSPQP	SMC5	1	Q8IY18
SIMKKSPFSGPTDPR	RELA	311	Q04206
GSQTKTPKLDPTMPP	XIRP1	1306	Q702N8
TQMAKPKPQTHAGPS	KIAA1958	231	Q8N8K9
TSSSPKKAPATPAPM	NACA	1486	E9PAV3
PPSPFGSMITVKSAK	MYO5C	596	Q9NQX4